Cabozantinib Tablets Manufacturer & Supplier

Indian Generic Medicines (IGM) is a well-known name in the global pharmaceutical supply chain. We supply compliant, high-quality generic and branded medicines across all therapeutic areas. As a reliable Cabozantinib Tablets Manufacturer & Supplier in India, we proudly serve markets across the USA, Europe, LATAM, Africa, Asia, the Gulf region, and Australia. With efficient cold-chain logistics and WHO-GMP-certified manufacturing, we provide timely and compliant global delivery.

Cabozantinib is an oral kinase inhibitor used for the treatment of various advanced cancers. It works by blocking multiple receptor tyrosine kinases (RTKs), which are involved in tumor growth, angiogenesis, and metastatic progression. Cabozantinib plays a critical role in renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer, and certain neuroendocrine tumors.

FDA-Approved Indications of Cabozantinib Tablets Include:

• Advanced Renal Cell Carcinoma (RCC) as monotherapy.
• First-line treatment of RCC in combination with nivolumab.
• Hepatocellular carcinoma (HCC) in patients previously treated with sorafenib.
• Locally advanced or metastatic Differentiated Thyroid Cancer (DTC) in adults and pediatric patients (12+ years) after prior VEGFR-targeted therapy, and who are radioactive iodine-refractory or ineligible.
• Previously treated, unresectable, locally advanced or metastatic pancreatic neuroendocrine tumors (pNET) in adults and pediatric patients (12+ years).
• Previously treated, unresectable, locally advanced or metastatic extra-pancreatic neuroendocrine tumors (epNET) in adults and pediatric patients (12+ years).

Common Side Effects of Cabozantinib May Include diarrhea, fatigue, decreased appetite, nausea, vomiting, high blood pressure (hypertension), hand-foot syndrome (palmar-plantar erythrodysesthesia), weight loss, hair color changes, liver enzyme elevations, and mucosal inflammation. Patients on Cabozantinib should be monitored for hypertension, thromboembolic events, gastrointestinal perforation, and wound healing complications, especially during and after surgery.

As a trusted Cabozantinib supplier and third-party manufacturer in India, we ensure the highest levels of quality and compliance. Our production meets WHO-GMP, US FDA, and EU-GMP standards. Our formulations are clinically accepted and supplied to both domestic and international markets with full regulatory documentation.

Choose IGM as Your Cabozantinib Tablets Supplier & Contract Manufacturing Partner:

When looking for a reliable Cabozantinib exporter, manufacturer, or supplier in India, Indian Generic Medicines (IGM) widely offers:

• A comprehensive pharmaceutical catalog featuring over 200,000+ formulations
• A network of 150+ certified manufacturing partners
• Access to 1,000+ approved suppliers worldwide
• Cold-chain shipping for sensitive oncology drugs
• Direct procurement from certified production units
• Affordable pricing, consistent supply timelines, and global regulatory support

We also offer Third-Party Manufacturing Services for Cabozantinib Tablets, ideal for pharmaceutical companies, NGOs, government health programs, and oncology clinics seeking private-label or bulk production support.

What is Cabozantinib?

Cabozantinib is an orally available tyrosine kinase inhibitor (TKI) that targets multiple receptors, including VEGFR, MET, AXL, and others involved in cancer cell proliferation, migration, and angiogenesis. It is marketed under brand names such as Cabometyx and Cometriq, depending on the indication.
Its multi-kinase inhibition allows for effective disruption of tumor growth and metastasis, particularly in cancers that have developed resistance to other treatments.

Uses of Cabozantinib Tablets:

Cabozantinib is used to treat:

• Advanced or metastatic renal cell carcinoma (RCC)
• HCC (liver cancer) after progression on sorafenib
• DTC (thyroid cancer) that is radioactive iodine-refractory and has progressed after VEGFR therapy
• pNET and epNET (well-differentiated neuroendocrine tumors of pancreatic or non-pancreatic origin) that are unresectable or metastatic, in adults and children aged 12 and above

Side Effects of Cabozantinib Tablets:

While effective in controlling tumor progression, Cabozantinib may lead to:

• diarrhea
• nausea
• mouth sores
• rash
• hand-foot syndrome
• hypertension
• thromboembolism
• anemia
• leukopenia
• elevated liver enzymes
• renal toxicity (less frequent but possible in long-term use)

Frequently Asked Questions (FAQs):

Conclusion:

Trust Indian Generic Medicines (IGM) as your best Wholesaler, Distributor, or Retail Partner for Cabozantinib Tablets in India. We provide seamless global access to this important oncology medicinal products with a commitment to uncompromised quality.

For fast procurement, affordable pricing, and worldwide delivery, we stands out as your preferred Cabozantinib tablets Manufacturer, Supplier & Exporter.

Reach out to us today for detailed assistance, regulatory guidance, and a tailored quote for contract manufacturing or bulk supply of Cabozantinib Tablets.